EUVIMEDEUVIMED entdecken
LeserbriefOpen Access

Letter: Low FODMAP Therapy in Paediatric Irritable Bowel Syndrome: Balancing Efficacy, Expectancy and Safety

Yousef Hakimi iD, Edward Giles

Alimentary Pharmacology & Therapeutics · 2026-10 · 64 (7) · 1021-1022

DOI: 10.1111/apt.70830 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 29.06.2026. Verfasst von Yousef Hakimi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Monash Health, Clayton, Victoria, Australia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Monash Health, Clayton, Victoria, Australia.
  • Department of Paediatrics, Monash University, Clayton, Victoria, Australia.
  • Centre for Innate Immunity and Infectious Disease, Hudson Institute of Medical Research, Clayton, Victoria, Australia.

ORCID-Profile: Yousef Hakimi

Zitieren

APA

Hakimi, Y., & Giles, E. (2026). Letter: Low FODMAP Therapy in Paediatric Irritable Bowel Syndrome: Balancing Efficacy, Expectancy and Safety. Alimentary Pharmacology & Therapeutics, 64(7), 1021-1022. https://doi.org/10.1111/apt.70830

Vancouver

Hakimi Y, Giles E. Letter: Low FODMAP Therapy in Paediatric Irritable Bowel Syndrome: Balancing Efficacy, Expectancy and Safety. Alimentary Pharmacology & Therapeutics. 2026;64(7):1021-1022. doi:10.1111/apt.70830

BibTeX
@article{Hakimi2026,
  author = {Hakimi, Yousef and Giles, Edward},
  title = {Letter: Low FODMAP Therapy in Paediatric Irritable Bowel Syndrome: Balancing Efficacy, Expectancy and Safety},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  volume = {64},
  number = {7},
  pages = {1021--1022},
  doi = {10.1111/apt.70830}
}
Kostenlos starten →